Your browser is old and is not supported. Upgrade for better security.

Herbal Botanical Products, LLC

We formulate and sell topical pain management products infused with CBD isolate, Nano CBD, and CBG

Last Funded September 2023

$52,400

raised from 14 investors

Highlights

1
💰 Proven Leadership Team with over $100 million raised over their career.
2
Fast-Growing CBD Industry is experiencing Exploding Demand
3
📈 High Operating Margins and Strong Financial Leadership
4
🙌 Highly Effective and Potent Product Set
5
🤝 Key Celebrity Endorsements and Partnerships

Our Team

After two successful exits (one for $45 million and another for $55 million), I was looking for the next best thing and a friend asked me to audit a CBD company he had invested in which is how I came to learn about the products, the inherent efficacy of the compounds, and the product margins.

Pitch

Herbal Botanical Products, LLC: Fast Facts

Herbal Botanical Products, LLC develops proprietary topical pain products infused with a combination of cannabinoids including CBD, CBG, CBN and select terpenes derived from the Cannabis Sativa L industrial hemp plant. Our customers use our topical pain products to help to manage a wide variety of chronic pain issues.

Key Highlights

We operate under the brand name Theá Panakeia Botanicals In Greek mythology, Panakeia was the goddess of natural remedies in Greek mythology, where she would treat people with natural potions & poultices to heal people. Because of the superior quality and effectiveness of our topical pain management products, we were selected to participate in Kevin Harrington’s Health & Wellness market campaign on Connected TV in 2020, through his company Shark Discoveries and As Seen on TV. We have also been offered the opportunity to be a Platinum Marketing Partner with The Arthritis Foundation, with access to their 600,000+ Members.

Strategic Partners

KEY INDUSTRY 

Health and Wellness; Pain Management


DUAL-ADDRESSABLE MARKET SIZE

The global chronic pain treatment market valued $77.8 billion in 2019, and it is expected to grow at a 6.5% CAGR during between 2020 and 2030. The CBD market is expected to reach 56.2 billion by 2028.


TARGET CUSTOMERS

Customers who have chronic pain issues, including arthritis patients & physical therapy patients. Typically, these individuals are affluent, 55+, college educated and lead active lifestyles.

Many CBD Products are Ineffective

Studies show that Cannabidiol (CBD) can be effective in the treatment of chronic pain, yet hundreds of CBD products on the market offer little to no efficacy for pain management.

The reason for this is the lack of formulation guidelines and the proliferation of low grade product with little to no CBD concentration, which leads to ineffectiveness.

It’s estimated that 95% of “ordinary” CBD (isolate) is not absorbed into the bloodstream, remaining trapped in the lymph nodes or dissolved by stomach acid, which further reduces effectiveness.

* Source: National Library of Medicine, publication PMC 7558665, “Towards Better Delivery of Cannabidiol (CBD)

Effective Topical CBD Solutions

Herbal Botanical Products, LLC, operating under the brand name Theá Panakeia Botanicals , provides pharmaceutical grade topical pain management products at fair prices to people dealing with chronic pain issues.

We use a combination of fully water soluble, nano-sized CBD, isolate CBD, CBG, CBN, and anti inflammatory terpenes, which creates an “entourage effect” that provides anti inflammatory boosts and high quality absorption, which increases.

BIOAVAILABILITY.

The result is increased effectiveness of the CBD effect, which consumers have expressed is their number one buying criteria when selecting CBD infused products.

The Science Behind the Products

All of our products are clinical grade with a focus on quality, concentration, effectiveness, and value. All products are designed to:

CBD is a proven anti inflammatory agent* and acts as a neural blocker for topical management of many types of chronic pain. When our topical pain creams are applied to an affected area, the active ingredients are absorbed through the dermis by following the hair follicles into the Endo-Cannabinoid System (ECS).

Available Products

Traction & Accomplishments

Business Model & Revenue Streams

REVENUE STREAM

Investment Opportunity

Herbal Botanical Products, LLC is seeking $124,000 in the form of Redeemable Preferred Equity Security.

T E R M S

The Company plans to issue Redeemable Preferred Equity Units at a value of $100.00

The Redeemable Units will have a mandatory redemption at the sixty-first month from issuance. The Company will also have the right to redeem the Units at any anniversary of the original issuance.

The Units will have an annual cumulative redemption premium of 25%. The initial investors who invest during the "Early Bird" period (defined as the first $124,000 or 1,240 Units), will receive, in addition to the cumulative annual dividends, a special "Issuance Dividend" of another 25% dividend.

If the Preferred Units remain outstanding for the full term the total return to initial investors will be $250 and subsequent Investors will receive $225 per Unit upon redemption, a 2.5X and 2.25X cash-on-cash return.

The Crowd also receives Product Perks equal to 20% of the invested amount - Larger Investment = More Free Products.

Company Valuation

Based on the offered securities structure the Company is valued at a premoney valuation of $12.5 million, depending on the final amount of equity issued.

Initial Investors Discount

Investors in the first $124,000 of the offering receive an issuance bonus dividend accrual of 25%.

Term/Duration

Up to 60 months

Redemption Premium

25% cumulative annual premium based on Par Value, paid quarterly in arrears

Funding will allow us to reach +- $40 to $50 million in revenue annually, which will produce $27 to $30 million in gross profit and roughly $15 million in annual operating income.

Investment Opportunity – Product Perks

Investors who participate in the General Offering will receive the following Product Perks:

Why Invest?

Growing Market

The global chronic pain treatment market was valued at $77.8 billion in 2019 and is expected to grow at a 6.5% CAGR between 2020 and 2030. The market size for topical pain products is $2.5 billion and expected to grow at a 6% CAGR. Plus, the CBD market is poised to reach $56.2 billion by 2028 resulting in a total addressable market for the Company of $134.0 billion.

Superior Products

Our pharmaceutical-grade products feature a combination of fully water-soluble nano-sized CBD, isolate CBD, and terpenes for maximum effectiveness, and increased bioavailability for greater effectiveness.

Outsized Gross Profit Margins

Even though our products are priced at or below market, gross margins remain at outsized levels (+- 70%) and there is pricing power for products that are of high quality and effectiveness.

Recurring Revenue model

Once customers use our pain products, almost all reorder creating a recurring revenue model which is much more valuable than a simple product sale model.

Key Partnerships

We were selected to participate in Kevin Harrington’s upcoming Health & Wellness market campaign on Connected TV. We are a marketing partner with The Villages News.com which has digital marketing assets serving The Villages in Florida, DMDatabase for email marketing addresses and we’re also establishing partnerships with The Arthritis Foundation &ForbesBooks.


Forward looking projections cannot be guaranteed.

Want even more details?


Click the image above for our full pitch deck!


Downloads

Overview